BioMarin Pharmaceutical Inc (MIL:1BMRN)
€ 57.18 (0%) Market Cap: 10.95 Bil Enterprise Value: 13.82 Bil PE Ratio: 177.51 PB Ratio: 2.01 GF Score: 59/100

BioMarin Pharmaceutical Inc. at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2026 / 02:00PM GMT
Sean Laaman
Morgan Stanley - Analyst

Good morning, everyone. I'm Sean Laaman, Head of US SMID cap biotech Equity Research here at Morgan Stanley, and welcome to our Global Healthcare Conference. Before we begin, I'll make you aware of some important disclosures. For those disclosures, see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.

And if you have any questions, please reach out to your Morgan Stanley sales representative. I welcome here today, President and CEO, Alexander Hardy; and EVP and CFO, Brian Mueller. Welcome to both of you. Alexander, I believe you wanted to make some introductory remarks before we kick off the formal Q&A part of the session. But thank you for your time today.

Alexander Hardy
BioMarin Pharmaceutical Inc. - President, Chief Executive Officer, Director

Thanks very much, Sean. Thanks very much for having us. Thanks to Morgan Stanley for hosting this. Yeah, I just want to say a few

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot